{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:50:36Z","timestamp":1773381036694,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T00:00:00Z","timestamp":1682812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["www.bloodresearch.or.kr"],"crossmark-restriction":true},"short-container-title":["Blood Res"],"published-print":{"date-parts":[[2023,4,30]]},"DOI":"10.5045\/br.2023.2023054","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T04:41:26Z","timestamp":1682484086000},"page":"S109-S113","update-policy":"https:\/\/doi.org\/10.5045\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Treatment after failure of frontline therapy of chronic myeloid leukemia in chronic phase including allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1007","volume":"58","author":[{"given":"Jieun","family":"Uhm","sequence":"first","affiliation":[{"name":"Division of Hematology & Oncology, Department of Internal Medicine, Hanyang University Hospital, Hanyang University College of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.66.2866"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.139337"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.1587.1587"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022457"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.74.7162"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0776-2"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030513"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002315"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0912614"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5045\/br.2021.2020260"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.8899"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.5"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01589-y"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-01111-2"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-080838"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/hon.894"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-010-1039-5"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-1516"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2013.09.011"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V118.21.2755.2755"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24423"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.181"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2014.10.005"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-127514"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2011.05.015"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-739086"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)00080-2"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021012082"},{"key":"ref29","unstructured":"U.S. Food and Drug Administration. FDA approves asciminib for Philadelphia chromosome-positive chronic myeloid leukemia 2021. Silver Spring, MD: US FDA, 2021 (Accessed March 20, 2023, at https:\/\/www.fda.gov\/drugs\/resources-information-approved-)."},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020009984"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-023-01829-9"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2022000328"},{"key":"ref33","unstructured":"Gratwohl A, Brand R, Apperley J, et al. Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 2006;91:513-21."},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.1.67"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-301341"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2015.193"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2011.194"}],"container-title":["Blood Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/pdf.medrang.co.kr\/BR\/2023\/058\/BR2058-S1-S109.pdf","content-type":"unspecified","content-version":"tdm","intended-application":"text-mining"},{"URL":"http:\/\/pdf.medrang.co.kr\/BR\/2023\/058\/BR2058-S1-S109.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T22:27:24Z","timestamp":1773354444000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bloodresearch.or.kr\/journal\/view.html?doi=10.5045\/br.2023.2023054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,30]]},"references-count":37,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2023,4,30]]}},"alternative-id":["10.5045\/br.2023.2023054"],"URL":"https:\/\/doi.org\/10.5045\/br.2023.2023054","relation":{},"ISSN":["2287-979X","2288-0011"],"issn-type":[{"value":"2287-979X","type":"print"},{"value":"2288-0011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,30]]},"assertion":[{"value":"https:\/\/www.bloodresearch.or.kr\/journal\/view.html?doi=10.5045\/br.2023.2023054","URL":"https:\/\/www.bloodresearch.or.kr\/journal\/view.html?doi=10.5045\/br.2023.2023054","name":"the_journal","label":"Blood Res","group":{"name":"multiple_resolution","label":"Full text available at:"}},{"value":"2023-03-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"\u00a9 2023 The Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis","name":"copyright","label":"Copyright","group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:\/\/creativecommons.org\/licenses\/by-nc\/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.","name":"license","label":"License","group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}}]}}